When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Brucellosis

Última revisión: 18 Jan 2026
Última actualización: 21 Oct 2025

Resumen

Definición

Anamnesis y examen

Principales factores de diagnóstico

  • history of contact with infected person
  • fever or chills
  • constitutional symptoms
  • arthralgia
  • joint swelling and tenderness
  • hepatomegaly and/or splenomegaly
Todos los datos

Otros factores de diagnóstico

  • nausea, vomiting, abdominal pain, constipation, diarrhea
  • pallor
  • lymphadenopathy
  • dry cough
  • chest signs
  • testicular pain
  • neck stiffness
  • cranial nerve palsy or focal central nervous system deficit
  • dullness to percussion, decreased air entry, crepitations
  • red eye
  • skin rashes
Todos los datos

Factores de riesgo

  • ingestion of contaminated foods
  • exposure to infected animal products
  • inhalation of infected aerosols
  • conjunctival contact with infected material
  • occupation with potential for exposure to Brucella species
  • travel to an endemic area
  • cuts or abrasions in skin
  • sexual contact with infected individual
  • newborn or infant of infected mother
  • recipient of blood products or of organ or tissue transplant
Todos los datos

Pruebas diagnósticas

Primeras pruebas diagnósticas para solicitar

  • blood culture
  • serologic tests
  • cerebrospinal fluid (CSF) analysis
  • cerebrospinal fluid (CSF) culture
  • synovial fluid analysis
  • synovial fluid culture
  • CBC
  • liver function tests
  • serum electrolytes
Todos los datos

Pruebas diagnósticas que deben considerarse

  • bone marrow culture
  • tissue biopsy
  • plain film x-rays of affected joints
  • chest x-ray
  • bone scan
  • CT or MRI scan of spine
  • CT or MRI scan of head
Todos los datos

Pruebas emergentes

  • polymerase chain reaction for detection and diagnosis of Brucella species
  • matrix-assisted laser desorption/ionization time of flight (MALDI-TOF) mass spectrometry

Algoritmo de tratamiento

Agudo

uncomplicated disease

complicated disease

Colaboradores

Autores

Nicholas J. Beeching, MA, BM BCh, FRCP, FRACP, FFTM RCPS (Glasg), FESCMID, DCH, DTM&H

Consultant and Emeritus Professor of Tropical and Infectious Diseases

Royal Liverpool University Hospital

Liverpool School of Tropical Medicine

Liverpool

UK

Divulgaciones

NJB is partially supported by the National Institute of Health Research Health Protection Unit in Emerging and Zoonotic Infections at the University of Liverpool and the UK Health Security Agency. Views expressed in this topic are those of the contributor and do not necessarily represent the official position of the National Health Service, the National Institute for Health Research, the Department of Health, or the UK Health Security Agency. NJB is an author of references cited in this topic.

Alessandro Gerada, MD, MRCP, FRCPath

Consultant in Clinical Microbiology

Liverpool Clinical Laboratories

Royal Liverpool University Hospital

Liverpool

UK

Divulgaciones

AG is an author of several references cited in this topic.

Sherine Thomas, MBChB, MRCP, DTMH

Consultant in Infectious Diseases

Whipps Cross Hospital

London

UK

Divulgaciones

ST declares that she has no competing interests.

Revisores por pares

Mical Paul, MD

Infectious Diseases Consultant

Unit of Infectious Diseases

Rabin Medical Center

Beilinson Hospital

Petah-Tikva

Israel

Divulgaciones

MP declares that she has no competing interests.

Edward J. Young, MD

Professor of Medicine

Section of Infectious Diseases

Department of Medicine

Baylor College of Medicine

Houston

TX

Divulgaciones

EJY declares that he has no competing interests.

Agradecimiento de los revisores por pares

Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.

Divulgaciones

Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Centers for Disease Control and Prevention. Brucellosis reference guide: exposures, testing and prevention. Feb 2017 [internet publication].Texto completo

World Health Organization. Brucellosis in humans and animals. 2006 [internet publication].Texto completo

Yousefi-Nooraie R, Mortaz-Hejri S, Mehrani M, et al. Antibiotics for treating human brucellosis. Cochrane Database Syst Rev. 2012 Oct 17;10:CD007179.Texto completo  Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad